# Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant

> **NCT04230356** · PHASE2 · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 180 (estimated)

## Conditions studied

- Allogeneic Stell Cell Transplant
- Viral Infection

## Interventions

- **BIOLOGICAL:** Viral Specific T-cells (VSTs) Scheduled
- **BIOLOGICAL:** Viral Specific T-cells (VSTs) Treatment

## Key facts

- **NCT ID:** NCT04230356
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-27
- **Primary completion:** 2028-03
- **Final completion:** 2028-06
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04230356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04230356, "Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04230356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*